Is this email not displaying correctly? View it in your browser.
 
Newswise - News for JournalistsNewswise - pix
Newswise Special Wire
Tuesday, January 28, 2020

Public edition | newswise.com

Newswise Cancer Research Wire for 28-Jan-2020
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.


Cancer Research


First-of-its-Kind Technology Lights Up Lung Cancer Cells, Helps Improve Patient Outcomes

A groundbreaking tumor-highlighting technology—OTL38—enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible.

– The Society of Thoracic Surgeons

56th Annual Meeting of The Society of Thoracic Surgeons

Embargo expired on 27-Jan-2020 at 13:30 ET


New Drug Target for Prostate Cancer Found in the Non-Coding Genome

Scientists at Princess Margaret Cancer Centre have identified the drivers of a crucial gene involved in prostate cancer, revealing new targets for drug design.

– University Health Network (UHN)

Nature Communications, 2020

Embargo expired on 23-Jan-2020 at 05:00 ET


Study Examines Genetic Testing in Diverse Young Breast Cancer Patients over a Decade

Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017. They found that among 1,503 diverse young breast cance...

– Florida Atlantic University

Journal of Cancer Education


Advisory: Resarchers Develop Ultasensitive Blood Test to Predict Recurrence Of Gastric Cancers

Researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, developed a blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is stil...

– Johns Hopkins Medicine

Nature Communications


Tiny containers transport targeted treatments

Promising intracellular protein-based therapeutics have been of limited use due to the difficulty of delivery into diseased cells. Now bioengineers have developed nanoparticles that can deliver these therapeutics to their targets—avoiding degradati...

– National Institute of Biomedical Imaging and Bioengineering

Science Advances, Dec-2019; R01EB022148


AI can jump-start radiation therapy for cancer patients

Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.

– UT Southwestern Medical Center

Medical Physics


Study Examines Prostate Cancer Treatment Decisions

The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by Vanderbilt University Medical Center, is a multi-site research study conducting long-term followup on men who were diagnosed ...

– Vanderbilt University Medical Center

JAMA


University Hospitals Seidman Cancer Center treats its first glioblastoma patient with genetically modified poliovirus

University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH is the only Midwest site partici...

– University Hospitals Cleveland Medical Center

New England Journal of Medicine


Why eating yogurt may help lessen the risk of breast cancer

One of the causes of breast cancer may be inflammation triggered by harmful bacteria say researchers.

– Lancaster University

Medical Hypotheses


Researchers uncover two-drug combo that halts the growth of cancer cells

UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combo that halts the growth of cancer cells that carry HER2 mutations.

– UT Southwestern Medical Center

Cancer Cell


Decline in Late Stage Cancer Diagnoses After Health Reform Law

Advanced stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research.

– Health Sciences at the University of Pittsburgh

Medical Care; RSG-16-017-01-CPHPS; P30 CA047904 ; Magee-Womens Research Institute and Foundation


Is it time to stop ringing the cancer bell?

A study published in the International Journal of Radiation Oncology • Biology • Physics finds that patients who celebrate the end of cancer treatment by ringing a bell report more distressful memories of treatment than those who finish without r...

– American Society for Radiation Oncology (ASTRO)

International Journal of Radiation Oncology * Biology * Physics


Study Uncovers Unexpected Connection Between Gliomas, Neurodegenerative Diseases

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.

– Michigan Medicine - University of Michigan

Science Translational Medicine, Jan-2020


Medicinal cannabis may not ease sleep problems in the long run

Medicinal cannabis might not ease sleep problems in people with chronic pain over the long term, because frequent users might build up tolerance to its sleep-inducing effects, suggests preliminary research published online in BMJ Supportive & Palliat...

– BMJ

BMJ Supportive & Palliative Care


International Research Team Confirms Potential Glioblastoma Inhibitors

However, San Diego Supercomputer Center (SDSC) Research Scientist Igor Tsigelny recently collaborated Researchers from the San Diego Supercomputer at UC San Diego and colleagues from Sweden’s Karolinska Institute and the Pasteur Institute in France...

– University of California San Diego

Proceedings of the National Academy of Sciences, Jan-2020ye


Cancer Experts and Features


Medical Minute: Trying to quit smoking? Don’t go it alone.

We live in an era of self-empowerment. But when it comes to quitting smoking, going it alone isn’t the best approach. Read on for effective strategies from Penn State Health experts.

– Penn State Health


GW Cancer Center Expands Clinical Trial Offerings for Patients with High Risk Cutaneous Squamous Cell Carcinoma

The Cutaneous Oncology Program at the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. The study, sponsored by Regeneron, will examine outcomes for patients tre...

– George Washington University


NCCN Oncology Research Program to Oversee Trials of the FGFR Inhibitor Futibatinib in Tumors with Aberrant FGFR Expression, in Collaboration with Taiho Oncology

The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) announces plans to evaluate futibatinib (TAS-120), an inhibitor of the fibroblast growth factor receptor (FGFR).

– National Comprehensive Cancer Network® (NCCN®)


The Pediatric Cancer Genome Project at 10: The impact lives on

Ten years ago this week St. Jude Children’s Research Hospital and Washington University School of Medicine unveiled an ambitious collaboration to identify the genetic changes that lead to some of the world’s deadliest childhood cancers. The resea...

– St. Jude Children's Research Hospital


A Menu of Brain Cancer Treatments

Sara Piccirillo, PhD, is passionate about finding a way to beat glioblastoma, the most aggressive type of brain cancer. Her research focuses on a feature of glioblastoma tumors that appears to be the source of their strength: the extreme differences ...

– University of New Mexico Comprehensive Cancer Center


Basketball Game Blurs Party Lines

At the end of each legislative session, New Mexico’s senators and representatives lace up to play a hotly-contested basketball game. No one officially tracks how many games each team has won — or any other statistics — because, in the end, the ...

– University of New Mexico Comprehensive Cancer Center


Cancer Announcements


UIC receives archives of Chicago’s first hospice

In addition to being the first hospice in Chicago, Horizon Hospice helped pass the Illinois Hospice Licensing Law in 1983. The University of Illinois at Chicago has receive its archives.

– University of Illinois at Chicago


Media alert: The Allied Genetics Conference (TAGC) 2020

Reporters are invited to attend The Allied Genetics Conference (TAGC), to be held April 22-26, 2020 in National Harbor, Maryland, just 30 minutes from downtown Washington DC. TAGC 2020 will feature the latest discoveries from researchers at the leadi...

– Genetics Society of America

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 BMJ

 Penn State Health

 Health Sciences at the University of Pittsburgh

 George Washington University

 Michigan Medicine - University of Michigan

 UT Southwestern Medical Center

 Lancaster University


Subscribe / Unsubscribe
Edit my preferences

© 2020 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us